T&R Biofab Co., Ltd. (KOSDAQ:246710)

South Korea flag South Korea · Delayed Price · Currency is KRW
3,045.00
-25.00 (-0.81%)
Apr 29, 2026, 2:50 PM KST
-26.85%
Market Cap 146.04B
Revenue (ttm) 26.97B
Net Income (ttm) -34.94B
Shares Out 47.57M
EPS (ttm) -1,093.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 149,343
Average Volume 378,213
Open 3,070.00
Previous Close 3,070.00
Day's Range 2,995.00 - 3,100.00
52-Week Range 1,127.00 - 4,925.00
Beta 0.61
RSI 45.99
Earnings Date Jun 1, 2026

About T&R Biofab

T&R Biofab Co., Ltd. develops and commercializes various regenerative medical technologies. It offers 3D-printed medical devices; and bio-surgical solutions, which includes wound dressing and acellular dermal matrix, as well as biomaterials and biopharmaceuticals. The company was founded in 2013 and is based in Siheung-si, South Korea. [Read more]

Industry Medical - Specialties
Sector Healthcare
Founded 2013
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 246710
Full Company Profile

Financial Performance

In 2025, T&R Biofab's revenue was 26.97 billion, an increase of 453.32% compared to the previous year's 4.87 billion. Losses were -34.94 billion, 355.1% more than in 2024.

Financial Statements

News

There is no news available yet.